Gero

Thanks @Nasdaq for celebrating our recent partnership with @chugai_cc to develop novel therapies for age-related diseases. 🧬🧬 Read the news: shorturl.at/JZAck

In this episode (# 357) of The Drive, Brian Kennedy, Ph.D., shares insights from ongoing human aging studies, including clinical trials of rapamycin and how dosing strategies, timing, and exercise may influence outcomes. bit.ly/40sLs10

We’re thrilled to welcome @BKennedy_aging to our Board of Directors! Read our release: globenewswire.com/news-release/2…

New Power Pair in #longevity science — Gero(@hacking_aging) x Chugai Pharmaceutical (@chugai_cc). Chugai harness its proprietary antibody engineering technologies with Gero's AI platform to develop anti-aging therapies— Deal value may top $1 billion. biospace.com/business/roche…

The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in aging-related diseases. Chugai will then develop antibody-based drugs based on the findings. #AI #biospace hubs.li/Q03w3sCD0

.@endpts spoke with our CEO @fedichev about the recent Chugai deal and what this means for #longevity @ky_lahucik endpoints.news/roche-backed-c…

Thanks @LongevityTech for covering our deal with Chugai. Milestones plus escalating royalties position Gero for industry-leading longevity returns in major therapeutic alliance with Chugai. 🔥🔥 Read the article: 👇👇 longevity.technology/news/ai-driven…

Thanks @biospace for covering our deal with Chugai today to develop novel therapies for age-related chronic diseases. 🧬🧬 Read the article: biospace.com/business/roche…

Roche's Chugai places $250M wager on Gero's AI to crack age-related disease $RHHBY firstwordpharma.com/story/5979054

BREAKING: Gero Signs Potential Multi-Billion-$  Deal to Fuel Our Mission to Stop Aging  -- A few years ago, my son, aged five at the time, asked what happened to the dinosaurs. After learning their sad story, he told me he wanted to fly to the Moon and defend Earth from falling…

We’re excited to announce a potential multi-billion licensing agreement with Chugai to develop novel therapies for age-related diseases. #longevity 🧬🧬 shorturl.at/HC6I8

Gero unveils AI model for small molecule design without structure #longevity #longevityinnovation #AI longevity.technology/news/gero-unve…

𝐀𝐈 𝐍𝐞𝐰𝐬: Singapore based @hacking_aging, a ompany focused on small molecules for aging conditions, launched ProtoBind-Diff, a model using amino acid sequences rather than structure models for discovery. CEO @fedichev explains the idea. Full video: biotechtv.com/post/gero-june…

Thanks @fwpharma for featuring the launch of ProtoBind-Diff small molecule AI discovery model. 🧬🧬 Read the article: firstwordpharma.com/story/5976106

🚀 We’re excited to announce the launch of ProtoBind-Diff, a masked diffusion language model that generates small molecules conditioned solely on protein sequences. #AI #drugdiscovery 🧬🧬 Read our release: alturl.com/twjet

Excited to share that I will be joining @athena_dao_’s Demo Day on Wednesday, June 25th, at 9:00 AM PT / 12:00 PM ET / 6:00 PM CET. I’ll be talking about my work APPLY TO ATTEND 👇 lu.ma/0aki5i4g

Could scientists have been getting it wrong all along? In Ep. 6 of Decoding Longevity, @fedichev ( @hacking_aging ) explains why animal models are misleading us—and what to do about it.